The voice for compounding pharmacy  |  October 4, 2019
The USP appeal: Everything you need to know
As you know - at least, we hope you know - USP in August rejected three appeals by compounding pharmacy groups, including one to which IACP was a party, regarding beyond-use date restrictions in the new <795> and <797> chapters. As a result, IACP and its partners have formally requested a hearing by a USP panel whose appointees are outlined in the USP Bylaws. USP has not yet set a hearing date, but announced recently that it has postponed the effective date of chapters <795>, <797> and <825> indefinitely as a result of BUD-date appeals.